(Q37470872)

English

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression

scientific article published on October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

Eva Hellström-Lindberg

9

object named as

Eva Hellström-Lindberg

0 references

Brigitte Schlegelberger

8

object named as

Brigitte Schlegelberger

0 references

Andrea Pellagatti

object named as

Andrea Pellagatti

3

0 references

Jacqueline Boultwood

object named as

Jacqueline Boultwood

6

0 references

Gudrun Göhring

4

object named as

Gudrun Göhring

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Martin Jädersten

1

object named as

Martin Jädersten

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

James S. Wainscoat

5

object named as

James S Wainscoat

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

Leonie Saft

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Anna Porwit

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Eva Hellström-Lindberg

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

1 October 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

94

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1762-1766

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

23 August 2017

Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

23 August 2017

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

23 August 2017

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

23 August 2017

Rules for making human tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

23 August 2017

Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

2 September 2018

Targeted therapies in myelodysplastic syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

2 September 2018

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

2 September 2018

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

2 September 2018

Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

2 September 2018

Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791931

2 September 2018

Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno

1 reference

https://pubmed.ncbi.nlm.nih.gov/19797731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q)

1 reference

https://pubmed.ncbi.nlm.nih.gov/19797731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19797731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19797731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2009.011528

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37470872&oldid=2137763316"